Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 132,149 | 316,727 | 264,249 | 131,468 | 23,565 |
| Marketable Securities | 223,185 | N/A | N/A | N/A | N/A |
| Receivables | 120,111 | N/A | N/A | N/A | N/A |
| Inventories | 39,563 | N/A | N/A | N/A | N/A |
| Other current assets | 11,716 | 0 | 0 | 0 | 0 |
| TOTAL | $603,406 | $328,281 | $272,339 | $136,665 | $24,035 |
| Non-Current Assets | |||||
| PPE Net | 9,340 | 8,152 | 6,248 | 2,344 | 26 |
| Investments And Advances | 1,176 | 5,338 | 11,414 | 7,847 | 2,753 |
| Intangibles | 39,087 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 33,966 | 2,493 | 11 | 32 | 203 |
| TOTAL | $83,569 | $15,983 | $17,673 | $10,223 | $2,982 |
| Total Assets | $686,975 | $344,264 | $290,012 | $146,888 | $27,017 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48,476 | 14,071 | 10,752 | 4,721 | 746 |
| Accrued Expenses | 166,630 | 52,102 | 8,782 | 4,708 | 2,980 |
| Other current liabilities | 62,500 | N/A | N/A | N/A | N/A |
| TOTAL | $277,606 | $66,173 | $19,534 | $9,429 | $7,942 |
| Non-Current Liabilities | |||||
| Long Term Debt | 267,458 | N/A | N/A | N/A | 595 |
| Other Non-Current Liabilities | 534,100 | 285,515 | 119,558 | 5,488 | 20,100 |
| TOTAL | $801,558 | $285,515 | $119,558 | $5,488 | $20,838 |
| Total Liabilities | $1,079,164 | $351,688 | $139,092 | $14,917 | $28,780 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,915 | 58,283 | 44,263 | 36,520 | N/A |
| Common Shares | 1,249,547 | 881,426 | 554,384 | 311,061 | 19,944 |
| Retained earnings | -1,739,169 | -972,373 | -443,568 | -202,646 | -75,456 |
| Other shareholders' equity | -1,505 | 0 | 0 | 0 | 43,270 |
| TOTAL | $-392,189 | $-7,424 | $150,920 | $131,971 | $-1,763 |
| Total Liabilities And Equity | $686,975 | $344,264 | $290,012 | $146,888 | $27,017 |